CEOi held a panel discussion at the International Conference on Alzheimer's and Parkinson Disease (AD/PD) 2024, "Exploring Blood-Based Biomarker Adoption: Insights from Real-World Practice." The discussion was moderated by George Vradenburg, Convener of CEOi, and featured Ana Pereira, Mount Sinai; Robert Perneczky, University of Munich; and Richard Batrla, Eisai.